Literature DB >> 30282815

Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

Emiliano Trias1, Peter H King2,3, Ying Si2,3, Yuri Kwon2, Valentina Varela1, Sofía Ibarburu1, Mariángeles Kovacs1, Ivan C Moura4,5,6,7,8,9, Joseph S Beckman10, Olivier Hermine4,5,6,7,8,9,11,12,13, Luis Barbeito1.   

Abstract

Neuroinflammation is a recognized pathogenic mechanism underlying motor neuron degeneration in amyotrophic lateral sclerosis (ALS), but the inflammatory mechanisms influencing peripheral motor axon degeneration remain largely unknown. A recent report showed a pathogenic role for c-Kit-expressing mast cells mediating inflammation and neuromuscular junction denervation in muscles from SOD1G93A rats. Here, we have explored whether mast cells infiltrate skeletal muscles in autopsied muscles from ALS patients. We report that degranulating mast cells were abundant in the quadriceps muscles from ALS subjects but not in controls. Mast cells were associated with myofibers and motor endplates and, remarkably, interacted with neutrophils forming large extracellular traps. Mast cells and neutrophils were also abundant around motor axons in the extensor digitorum longus muscle, sciatic nerve, and ventral roots of symptomatic SOD1G93A rats, indicating that immune cell infiltration extends along the entire peripheral motor pathway. Postparalysis treatment of SOD1G93A rats with the tyrosine kinase inhibitor drug masitinib prevented mast cell and neutrophil infiltration, axonal pathology, secondary demyelination, and the loss of type 2B myofibers, compared with vehicle-treated rats. These findings provide further evidence for a yet unrecognized contribution of immune cells in peripheral motor pathway degeneration that can be therapeutically targeted by tyrosine kinase inhibitors.

Entities:  

Keywords:  ALS; Inflammation; Mast cells; Neuroscience; Neutrophils

Mesh:

Substances:

Year:  2018        PMID: 30282815      PMCID: PMC6237484          DOI: 10.1172/jci.insight.123249

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  62 in total

1.  Brain mast cell degranulation regulates blood-brain barrier.

Authors:  X Zhuang; A J Silverman; R Silver
Journal:  J Neurobiol       Date:  1996-12

2.  Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle.

Authors:  J Pablo Abonia; Daniel S Friend; William G Austen; Francis D Moore; Michael C Carroll; Rodney Chan; Jalil Afnan; Alison Humbles; Craig Gerard; Pamela Knight; Yoshihide Kanaoka; Shinsuke Yasuda; Nasa Morokawa; K Frank Austen; Richard L Stevens; Michael F Gurish
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

3.  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

Authors:  D Frey; C Schneider; L Xu; J Borg; W Spooren; P Caroni
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

4.  Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice.

Authors:  Francis X Pizza; Jennifer M Peterson; Joel H Baas; Timothy J Koh
Journal:  J Physiol       Date:  2004-11-18       Impact factor: 5.182

Review 5.  Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases.

Authors:  Scott T Brady; Gerardo A Morfini
Journal:  Neurobiol Dis       Date:  2017-04-11       Impact factor: 5.996

Review 6.  The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.

Authors:  S J Galli; M Tsai; B K Wershil
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

7.  Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

Authors:  Isaac M Chiu; Hemali Phatnani; Michael Kuligowski; Juan C Tapia; Monica A Carrasco; Ming Zhang; Tom Maniatis; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

8.  Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  J Hegedus; C T Putman; N Tyreman; T Gordon
Journal:  J Physiol       Date:  2008-05-08       Impact factor: 5.182

9.  Mast cell chemotaxis - chemoattractants and signaling pathways.

Authors:  Ivana Halova; Lubica Draberova; Petr Draber
Journal:  Front Immunol       Date:  2012-05-25       Impact factor: 7.561

Review 10.  Mast Cell: A Multi-Functional Master Cell.

Authors:  Melissa Krystel-Whittemore; Kottarappat N Dileepan; John G Wood
Journal:  Front Immunol       Date:  2016-01-06       Impact factor: 7.561

View more
  33 in total

1.  Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.

Authors:  Emiliano Trias; Mariángeles Kovacs; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Ivan C Moura; Olivier Hermine; Joseph S Beckman; Luis Barbeito
Journal:  Glia       Date:  2019-12-20       Impact factor: 7.452

2.  Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease.

Authors:  Joshua D Crapser; Joseph Ochaba; Neelakshi Soni; Jack C Reidling; Leslie M Thompson; Kim N Green
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

3.  Characterization of neutrophil-neuronal co-cultures to investigate mechanisms of post-ischemic immune-mediated neurotoxicity.

Authors:  Nguyen Mai; Viollandi Prifti; Minsoo Kim; Marc W Halterman
Journal:  J Neurosci Methods       Date:  2020-05-20       Impact factor: 2.390

Review 4.  Adipose-Derived Mesenchymal Stem Cells Combined With Extracellular Vesicles May Improve Amyotrophic Lateral Sclerosis.

Authors:  Xichen Wang; Yong Zhang; Tian Jin; Benson O A Botchway; Ruihua Fan; Lvxia Wang; Xuehong Liu
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

Review 5.  Unveiling Leukocyte Extracellular Traps in Inflammatory Responses of the Central Nervous System.

Authors:  Francesca Colciaghi; Massimo Costanza
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

6.  Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice.

Authors:  Maria Chiara Trolese; Carlotta Scarpa; Valentina Melfi; Paola Fabbrizio; Francesca Sironi; Martina Rossi; Caterina Bendotti; Giovanni Nardo
Journal:  Mol Ther       Date:  2022-04-27       Impact factor: 12.910

Review 7.  Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases.

Authors:  Christine Péladeau; Jagdeep K Sandhu
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

8.  FGF23, a novel muscle biomarker detected in the early stages of ALS.

Authors:  Ying Si; Mohamed Kazamel; Michael Benatar; Joanne Wuu; Yuri Kwon; Thaddaeus Kwan; Nan Jiang; Dominik Kentrup; Christian Faul; Lyndsy Alesce; Peter H King
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 9.  Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk.

Authors:  Austin P Passaro; Abraham L Lebos; Yao Yao; Steven L Stice
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 10.  Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.

Authors:  Fabiola De Marchi; Ivana Munitic; Amedeo Amedei; James D Berry; Eva L Feldman; Eleonora Aronica; Giovanni Nardo; Donatienne Van Weehaeghe; Elena Niccolai; Nikolina Prtenjaca; Stacey A Sakowski; Caterina Bendotti; Letizia Mazzini
Journal:  Neurosci Biobehav Rev       Date:  2021-06-19       Impact factor: 9.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.